To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)
Public ClinicalTrials.gov record NCT00659750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray (200 mg Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older
Study identification
- NCT ID
- NCT00659750
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 418 participants
Conditions and interventions
Conditions
Interventions
- Ciclesonide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2003
- Primary completion
- Apr 30, 2004
- Completion
- Mar 31, 2005
- Last update posted
- Dec 1, 2016
2003 – 2005
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana/Nycomed | Encinitas | California | 92924 | — |
| Altana/Nycomed | Long Beach | California | 90806 | — |
| Altana/Nycomed | Los Angeles | California | 90025 | — |
| Altana/Nycomed | Mission Viejo | California | 92691 | — |
| Altana/Nycomed | San Diego | California | 92123 | — |
| Altana/Nycomed | San Jose | California | 95117 | — |
| Altana/Nycomed | Colorado Springs | Colorado | 80907 | — |
| Altana/Nycomed | Denver | Colorado | 80206 | — |
| Altana/Nycomed | Denver | Colorado | 80230 | — |
| Altana/Nycomed | Jupiter | Florida | 33458 | — |
| Altana/Nycomed | Rockville | Maryland | 20850 | — |
| Altana/Nycomed | North Dartmouth | Massachusetts | 02747 | — |
| Altana/Nycomed | Minneapolis | Minnesota | 55402 | — |
| Altana/Nycomed | St Louis | Missouri | 63141 | — |
| Altana/Nycomed | Missoula | Montana | 59804 | — |
| Altana/Nycomed | Brick | New Jersey | 08724 | — |
| Altana/Nycomed | Skillman | New Jersey | 08558 | — |
| Altana/Nycomed | Raleigh | North Carolina | 27607 | — |
| Altana/Nycomed | Winston-Salem | North Carolina | 27103 | — |
| Altana/Nycomed | Sylvania | Ohio | 43560 | — |
| Altana/Nycomed | Fort Worth | Texas | 76132 | — |
| Altana/Nycomed | Houston | Texas | 77084 | — |
| Altana/Nycomed | Madison | Wisconsin | 53792-9988 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00659750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2016 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00659750 live on ClinicalTrials.gov.